Table 2.
Mean (SD) | Range | Distribution** Shapiro-Wilk (p) | Descriptor | |
---|---|---|---|---|
LEVEL ONE MEASURES | --- | --- | --- | --- |
Age | In years | e.g., first episode | ||
Sex | %Female | |||
Race | %White | |||
Education level | In years | Primary/secondary | ||
LEVEL TWO MEASURES | --- | --- | --- | --- |
BD subtype | %BDI/BDII/NOS | |||
Psychosis Hx | %yes/no | Lifetime presence | ||
Current depressive sx | HDRS/MDRS score | mild/mod/severe | ||
Current manic sx | YMRS/other score | mild/mod/severe | ||
Age at onset dep | In years | |||
Age at onset mania | In years | |||
# Prior manias | ||||
#Prior depressions | ||||
# total episodes | Full mania/depression | |||
#Hospitalizations | ||||
#Suicide attempts | ||||
Comorbid substance dx | %yes/no | Lifetime presence | ||
Comorbid anxiety dx | %yes/no | Lifetime presence | ||
LEVEL THREE MEASURES | --- | --- | --- | --- |
Global cognition | Calculated g using PCA | |||
Premorbid IQ | e.g., proxy WRAT/NART | |||
Medications | ||||
Lithium | % Yes | |||
Anticonvulsants | % Yes | |||
Antipsychotics | % Yes | |||
Antidepressants | % Yes | |||
Benzodiazepines | % Yes | |||
Total number of psychotropic meds | Mean (SD) | |||
--- | --- | --- | --- | --- |
OUTCOME MEASURES | ||||
Global functioning | Provide name of scale | |||
Global functioning impaired | Provide name of scale | |||
Social functioning | Provide name of scale | |||
Occupational fx | Provide name of scale | |||
Independent living | Provide name of scale | |||
Employed | Yes/no |
Shapiro-Wilk test for normality should be reported for each measure